Wilson Tan

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 3

Top Topics

Major Depressive Disorder

Clinical Practice

Disease Activity

Top Venues

Neuropsychiatric disease and treatment

Janssen Pharmaceutical Companies of Johnson and Johnson

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Pharmaceutical Companies of Johnson and Johnson Apr 11 2016

Singapore

Asia Pacific Medical Affairs Therapeutic Area Lead :: Neuroscience & IDV

Publications

Gang Wang, Chang-Su Han, Chia-Yih Liu, Sandra Chan, Tadafumi Kato, Wilson Tan, Lili Zhang, Yu Feng, Chee H Ng
Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatric disease and treatment 16 (2020)
Maju Mathews, Srihari Gopal, Arun Singh, Isaac Nuamah, Katalin Pungor, Wilson Tan, Bernardo Soares, Edward Kim, Adam J Savitz
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies. Neuropsychiatric disease and treatment 16 (2020)
Chang-Su Han, Gang Wang, Sandra Chan, Tadafumi Kato, Chee H Ng, Wilson Tan, Lili Zhang, Yu Feng, Chia-Yih Liu
Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatric disease and treatment 16 (2020)